Japan has announced new tuberculosis (TB) screening requirements for certain foreign visa applicants. The latest phase will begin on November 2, 2026, affecting Indonesian nationals planning long-term stays.
The Japanese Immigration Services Agency introduced the policy in January 2025 to strengthen public health protection.
Japan Visa Rules 2026: Who Needs Medical Screening?
Under the updated requirements, Indonesian applicants must undergo tuberculosis screening from November 2.
Starting January 4, 2027, affected applicants must submit a Tuberculosis Clearance Certificate with their Certificate of Eligibility (COE) applications.
The screening requirement covers certain medium- and long-term visa categories, including eligible Digital Nomad visa applicants.
However, the new Indonesian screening schedule does not apply to all foreign nationals or Pakistani applicants.
TB Screening Requirements and Certificate Validity
Applicants must complete a chest X-ray examination at a Japanese government-approved medical institution.
After completing the required assessment, eligible applicants can obtain a Tuberculosis Clearance Certificate.
The certificate remains valid for 180 days from the examination date.
Japanese consulates may also require the document during visa processing.
Japan Expands Medical Screening Policy
Japan previously introduced screening requirements for applicants from the Philippines, Nepal, and Vietnam.
However, some visa categories remain exempt.
These include Specified Skilled Worker visas, certain government-funded exchange programmes, and eligible healthcare workers under approved agreements.
Foreign residents returning with valid re-entry permits may also qualify for exemptions.
Applicants should check their visa category and official Japanese immigration guidance before applying.
The expanded screening programme aims to identify tuberculosis risks while supporting safer international travel and immigration procedures.
